CYTEGRITY Trademark
Trademark Overview
On Friday, October 20, 2023, a trademark application was filed for CYTEGRITY with the United States Patent and Trademark Office. The USPTO has given the CYTEGRITY trademark a serial number of 98232780. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Wednesday, December 11, 2024. This trademark is owned by CSL Behring Gene Therapy, Inc.. The CYTEGRITY trademark is filed in the Treatment & Processing of Materials Services, Advertising, Business and Retail Services, Computer & Software Services & Scientific Services, Personal, and Legal & Social Services categories with the following description:
Biomanufacturing for others, namely, manufacturing of pharmaceuticals and of viral vectors and gene therapy vectors using biological organisms or viruses; custom manufacturing services of ex vivo, lentiviral stable cell lines; custom manufacturing services of lentiviral vectors by transient transfection; Biomanufacturing for others, namely, manufacturing of viral vectors and gene therapy vectors using biological organisms or viruses in the manufacturing process; biomanufacturing for others, namely, manufacturing of cell lines and cells using biological organisms or viruses in the manufacturing process; biomanufacturing for others, namely, manufacturing of biological preparations for use in industry and science, and cell cultures for medical purposes using biological organisms or viruses in the manufacturing process; Biomanufacturing process consulting.
Business consultation in the field of business process improvement for clinical manufacturing
Regulatory compliance consulting in the field of clinical manufacturing
Scientific and pharmaceutical research and development; medical research; biological research; Scientific laboratory services in in the field of viral vectors and gene therapy vectors; Scientific, pharmaceutical, and medical research in the field of bioproduction, regulatory pathway services, accessory proteins and alternative envelope proteins; Scientific research consulting in the field of clinical manufacturing
General Information
| Serial Number | 98232780 |
| Word Mark | CYTEGRITY |
| Filing Date | Friday, October 20, 2023 |
| Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
| Status Date | Wednesday, December 11, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Biomanufacturing for others, namely, manufacturing of pharmaceuticals and of viral vectors and gene therapy vectors using biological organisms or viruses; custom manufacturing services of ex vivo, lentiviral stable cell lines; custom manufacturing services of lentiviral vectors by transient transfection; Biomanufacturing for others, namely, manufacturing of viral vectors and gene therapy vectors using biological organisms or viruses in the manufacturing process; biomanufacturing for others, namely, manufacturing of cell lines and cells using biological organisms or viruses in the manufacturing process; biomanufacturing for others, namely, manufacturing of biological preparations for use in industry and science, and cell cultures for medical purposes using biological organisms or viruses in the manufacturing process; Biomanufacturing process consulting. |
| Goods and Services | Business consultation in the field of business process improvement for clinical manufacturing |
| Goods and Services | Regulatory compliance consulting in the field of clinical manufacturing |
| Goods and Services | Scientific and pharmaceutical research and development; medical research; biological research; Scientific laboratory services in in the field of viral vectors and gene therapy vectors; Scientific, pharmaceutical, and medical research in the field of bioproduction, regulatory pathway services, accessory proteins and alternative envelope proteins; Scientific research consulting in the field of clinical manufacturing |
Classification Information
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, October 25, 2023 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, December 11, 2024 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, October 25, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, December 11, 2024 |
| Primary Code | 045 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | CSL Behring Gene Therapy, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Pasadena, CA 91101 |
Trademark Events
| Event Date | Event Description |
| Tuesday, October 24, 2023 | NEW APPLICATION ENTERED |
| Wednesday, October 25, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, June 5, 2024 | ASSIGNED TO EXAMINER |
| Thursday, June 13, 2024 | NON-FINAL ACTION E-MAILED |
| Thursday, June 13, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, June 13, 2024 | NON-FINAL ACTION WRITTEN |
| Wednesday, September 11, 2024 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Wednesday, September 11, 2024 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Wednesday, December 11, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, December 11, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, December 11, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
